Multaq Lawsuit Filed Over Failure to Warn About Liver Injury Risks
Several plaintiffs have filed a Multaq lawsuit against the manufacturer, saying that the drug caused liver damage and heart problems.
Several plaintiffs have filed a Multaq lawsuit against the manufacturer, saying that the drug caused liver damage and heart problems.
A new study indicates that patients taking the heart drug Multaq are more likely to become hospitalized than patients taking similar heart drugs.
Concerns over potential side effects similar to those encountered with the Sanofi-Aventis heart drug Multaq may have contributed to Merck & Co.’s decision to drop development of a similar heart…
Despite growing concerns over the side effects of Multaq, a relatively new heart drug made by Sanofi-Aventis, researchers are preparing to launch another clinical trial in an effort to determine…
Federal health regulators have called for new limits on the use of Multaq, indicating that the relatively new heart drug may double the risk of death, stroke and heart failure…
Concerns over the potential side effects of Multaq, Sanofi-Aventis’s beleaguered heart drug, have led France to decide to no longer pay for the drug to be used by French citizens.
The findings of a new study suggest that the side effects of Multaq, a relatively new Sanofi-Aventis heart drug, could double the risk of heart disease for some users.
According to a new report, several newer drugs, including Pradaxa, Ampyra and Tracleer, appear to be causing a surge in reports of adverse health events and even patient deaths, raising…
Concerns over potential side effects of Multaq, a relatively new heart drug, have lead European health officials to restrict use of the drug and similar actions are expected soon in…
A recently published case report examines the risk of liver failure from Multaq, a relatively new heart drug that has been linked to an increased risk of liver damage as…